Rasha Aboelhassan: How about raising our expectations for MDT?
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“How about raising our expectations for MDT?
It should not be limited to developing a treatment plan for cancer patients, MDT can solve debates.
Highlighting the points of debates is the main goal of our MDT, while solving the debate is a great success.
These were the statements I made yesterday during the Onco Egypt conference.
Thanks to all speakers, chair persons of and the organizing, scientific committee.”
More posts featuring Rasha Aboelhassan.
Rasha Aboelhassan is a Senior Oncology Consultant at Nasser Institute Hospital. In addition to her clinical role, she volunteers as a reviewer for the World Journal of Surgical Oncology, contributing to advancements in the field and is in the Editorial Staff of Egyptian Journal of Human Genetics. Rasha has been accepted as a member of staging and Prognostic Factors Group of lung cancer SPFG.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023